As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
Where available, URLs for the references have been provided.
The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
Preparing papers for publication
Manuscripts are examined by two independent reviewers in a double-blind review process.
Manuscripts with positive opinions are accepted for publication.
The manuscript is sent to the corresponding author for galley proof.
Before publication, authors transfer the copyright of their manuscripts to "Nigerian Journal of Pharmaceutical Research".
Ensuring the Originality of Papers Published in the Journal
All materials submitted for publication in the journal are reviewed by two independent reviewers who assess both the content and the originality of the work. Double-blind review means that both the reviewer and author name(s) are not allowed to be revealed to one another for a manuscript under review.
All submitted articles must be accompanied by the authorsâ€™ declaration that the work has not been submitted to any other journal and has not previously been published.
By submitting an article to this journal the authors accept that it will be screened for plagiarism. All detected cases of scientific misconduct will be disclosed, including notification of the appropriate institutions.
The authors must reveal any potential financial conflict of interest related to the manuscript. Financial and other material support should be disclosed.
Include a concise, informative title of the manuscript, the authorsâ€™ names, departmental and institutional affiliations of each author, the name and complete address of the corresponding author, including telephone number and e-mail address. In cases of co-authorship, the type(s) of contribution made by each author must be specified by adding the applicable symbols to their names in the byline: A â€“ research concept and design; B â€“ collection and/or assembly of data; C â€“ data analysis and interpretation; D â€“ writing the article; E â€“ critical revision of the article; F â€“ final approval of article. Authors should also provide a running title of not more than 45 characters.
Articles require an abstract in English. It should not exceedÂ 250Â words and should consist of 5 paragraphs introduced by separate subheadings in the following order: Background, Objectives, Material and Methods, Results, Conclusions. All abbreviations used in the abstract should be clarified when they first appear in the text. For review articles, an unstructured abstract of from 150 to 200 words is requested. Provide no more than five key words for indexing.
Text (Blinded manuscript)
Doc or docx formats are recommended for text. Review articles should be no longer than 6000 words and original studies 5000 words. Original studies should be divided into the following sections: Introduction, Material and Methods, Results and Discussion, References. Each section should begin on a separate page. Use Times New Roman 12-point typeface. Cite references, figures, and tables consecutively as they appear in the text. Do not use footnotes. In general, use generic names for drugs. All results of measurements should be given in SI units. Financial and other material support should be disclosed and acknowledged.
The accuracy of references is the authorâ€™s responsibility. References should be cited selectively, especially those that provide the basis for a key statement. A maximum of 40 references for review articles, 30 for original papers, and 10 for other reports are requested. References should be cited in alphabetical order. The following are sample references:
Ofokansi, K.C., Akpa, P.A., Onuigbo, E.B and Ndu, O.O. (2010). Preliminary antimicrobial studies of the leaf extract ofÂ Hibiscus esculentus,Â Â Nig. J. Pharm. Sci. 6: 24-30.
Chapters in Books
Rossati M.L., Smith R., Krovis B.L.K.: Congestive heart failure. In: Heart Disease in Infants, Children, and Adolescents. Eds.: Moss A. J., Adams F., Williams & Wilkins, Baltimore 1988, 2nd ed., 169â€“179.
Jacobs, E.J. Dakes, K.C. and Reddy, P.K. (2010)Â Polymers and their applications in Pharmacy, 1stÂ Ed., John Willey & Sons Ltd., Chicago, USA, pp.130-145.
These should be numbered using Arabic numerals, with title and footnote at the top and bottom respectively.Â Each table should be typed on a separate sheet. Tables should include horizontal lines only.
Figures should be submitted on separate pages. Black and white color or grey shading is preferred. They should be numbered in Arabic numerals in order of appearance in the text, where they are referred to as Fig. 1, Fig. 2, etc. Figures that include more than one image should be organized economically and labeled as a, b, c, etc. (small letters). Under every figure a brief title has to be cited (Times New Roman 10, bold, spacing 1, example:Â Figure 1.Â Changes in blood pressure. In every figure all the abbreviations and non-standard units should be explained.
PhotographsÂ must be inÂ JPG or TIFFÂ format, preferredÂ resolution 300 dpi.
GraphsÂ must be inÂ GIF, TIFF, JPG or original excelÂ format, preferredÂ resolution 300 dpi.
These will be sent to the corresponding author (unless otherwise indicated) who should ensure that they are returned without delay.Â Order forms of reprints and price list will be sent along with the galley proof.
Ethical ConsiderationsÂ Â
It is the responsibility of authors using experimental animals and human subjects in their work to seek approval from the appropriate ethical committees.